Research Article
Parkinson’s Disease-Related Biomarkers That May Appear in Amphetamine Abusers
Table 2
Comparison of measured parameters between patients and controls.
| | Groups | | Mean | Std. error | value |
| SAP (ng/m) | Controls | 19 | 3.4 | 0.28 | — | Amphetamine addicts | 19 | 144.29 | 11.14 | 0.0001 | Parkinson’s patients | 19 | 140.88 | 11.41 | 0.0001 |
| CRP (ng/m) | Controls | 19 | 3.75 | 0.32 | — | Amphetamine addicts | 19 | 6.54 | 0.63 | 0.0001 | Parkinson’s patients | 19 | 5.46 | 0.41 | 0.012 |
| CC4 (ng/m) | Controls | 19 | 22.73 | 0.46 | — | Amphetamine addicts | 19 | 21.2 | 0.75 | 0.191 | Parkinson’s patients | 19 | 20.62 | 1.01 | 0.065 |
|
|
Data are expressed as . Difference between participants and controls was made using one-way ANOVA test. |